Bansagon, Monie Jane M.

HRN: 26-34-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2025
CEFUROXIME 1.5GM (VIAL)
01/03/2025
01/10/2025
IVTT
1.5 GMS
Q8
TMSAF
Waiting Final Action 
01/03/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/03/2025
01/10/2025
IVTT
500MG
Q8
TMSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: